Finnhub · Apr 22, 2026
Delay in Medicare pilot for obesity drugs may not hurt near-term demand, analysts say
A delay in a Medicare pilot to cover obesity drugs due to health insurers' hesitation to participate in the program is unlikely to dent near-term demand for weight-loss treatments, analysts said. ...


